Fierce Biotech

Syneos Health scoops up Chinese CRO to secure place in ‘rapidly growing market’

Published

on

North Carolina-based contract research organization Syneos Health is making a play to capitalize on China’s rapidly ascendant biopharma industry. Syneos has acquired Chinese CRO Bestudy to secure a foothold in the Asian nation.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version